Australia-based not-for-profit organisation Crohn’s Colitis Cure (CCCure) has recently launched subscription-based access to its registry of data on patients dealing with inflammatory bowel diseases.
The IBD-focused charity claims to have one of the world's largest databases of real-time patient-reported and clinical data on IBD, including Crohn's disease, ulcerative colitis, and IBD-undetermined...
The German Federal Institute für Drugs and Medical Devices (BfArM) has added a new digital therapeutic to its digital health applications (DiGA) directory for public reimbursement.
Cara Care is the first DiGA that addresses gastroenterological issues and widespread digestive health problems such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), food and reflux intolerances.
The...
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD).
This is the first collaboration between the two companies, pairing Ferring’s medical expertise with CytoReason’s artificial intelligence (AI) platform to build cell-centred disease models.
CytoReason is developing a...
Nordic digital therapeutics company SidekickHealth is partnering with pharma giant Pfizer to launch a digital therapeutics platform, in a deal thought to be worth more than $8 million.
The solution combines scientific expertise and digital technologies, giving patients a tool to help them maintain healthy lifestyles and improve their disease management and quality of life, while providing...
A new company out of London called Bold Health is combining digital tools and cognitive behavioral therapy with the aim of helping patients improve their gut health.
Earlier this month, the company launched its first product, Zemedy, an app targeted at treating irritable bowel syndrome symptoms through a combination of CBT, hypnotherapy exercises and stress management techniques.
“There is a...
Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers.
WHAT THEY DO
The company’s lead product is Regulora, a treatment tackling the cognitive, behavioral and affective factors that can trigger...
Oshi Health, a digital startup focused on digestive health, has launched a mobile app specifically designed to help inflammatory bowel disease patients understand and manage their condition.
“What’s interesting about inflammatory bowel disease is that patients have very unique, individualized experiences,” Oshi CEO Daniel Weinstein told MobiHealthNews. “Some patients experience frequent,...
A software platform developed at Mount Sinai comprising of a mobile app for patients and a decision support dashboard for practitioners can improve inflammatory bowel disease (IBD) patients’ quality of care, according to clinical data recently presented at the Advances in Inflammatory Bowel Diseases Conference.
By implementing tools that allow care teams to monitor symptoms and more conveniently...
Cara, a Berlin-based startup building a medical app for digestive health (a space the company has boldly dubbed “poop tech”), has raised a $2 million seed round. Atlantic Labs led the round, and additional investments came from angel investors. The company does business as Cara, the name of its app, but is officially known as HiDoc.
“Digestive issues are still a taboo topic but we are now making...
Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson & Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company Nippon Shinyaku, and an app for...
